GIGLIONE, CLAUDIA
GIGLIONE, CLAUDIA
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Mostra
records
Risultati 1 - 6 di 6 (tempo di esecuzione: 0.0 secondi).
UNVEILING THE ADVERSE EFFECTS OF POLYSTYRENE NANOPLASTICS IN THE HUMAN-DERIVED HEPG2-OA STEATOTIC-LIKE MODEL, VALIDATING DYSFUNCTIONAL HUMAN-DERIVED SW872 ADIPOCYTE IN VITRO MODELS FOR THE STUDY OF CARDIOMETABOLIC DISEASES, AND ASSESSING TRIMETHYLAMINE N-OXIDE IN A PLIC STUDY SUB-COHORT
2025 C. Giglione
Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk
2025 H. Berisha, R. Hattab, L. Comi, C. Giglione, S. Migliaccio, P. Magni
Evaluation of Metabolic Dysfunction-Associated Fatty Liver Disease-Related Pathogenic Mechanisms in Human Steatotic Liver Cell-Based Model: Beneficial Effects of Prunus domestica L. subsp. syriaca Extract
2025 L. Comi, C. Giglione, F. Tolaj Klinaku, L. Da Dalt, H. Ullah, M. Daglia, P. Magni
Valorizing Agro‐Food Waste for Nutraceutical Development: Sustainable Approaches for Managing Metabolic Dysfunction‐Associated Steatotic Liver Disease and Related Co‐Morbidities
2025 L. Comi, C. Giglione, F.T. Klinaku, F. Pialorsi, V. Tollemeto, M. Zurlo, A. Seneci, P. Magni
An integrated view of the pathophysiological crosstalk between adipose tissue, bone and cardiovascular system in men and women
2025 F.T. Klinaku, L. Comi, C. Giglione, P. Magni
Nutraceutical alternatives to red yeast rice extract/monacolin K for moderate hypercholesterolaemia: Current evidence and knowledge gaps
2022 L. Comi, C. Giglione, F. Tolaj, C. Parolini, C. Olivieri, M. Ruzza, V. Tollemeto, M. Zurlo, F. Pialorsi, A. Seneci, P. Magni